ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING

Burgess Andrew; Goon Ken; Attia John; Palazzi Kerrin; Brannan John; Grainge Christopher

首页> 外文期刊>Respirology : >ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING

【24h】

ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING

机译：特发性肺纤维化（IPF）中抗纤维化处理的资格取决于肺功能测试中使用的预测方程

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2017年第3期|共1页
作者
Burgess Andrew; Goon Ken; Attia John; Palazzi Kerrin; Brannan John; Grainge Christopher;
展开▼
作者单位

John Hunter Hosp Newcastle NSW Australia;

John Hunter Hosp Newcastle NSW Australia;

John Hunter Hosp Newcastle NSW Australia;

Hunter Med Res Inst Newcastle NSW Australia;

John Hunter Hosp Newcastle NSW Australia;

John Hunter Hosp Newcastle NSW Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING [J] . Burgess Andrew, Goon Ken, Attia John, Respirology : . 2017,第Suppla3期

机译：特发性肺纤维化（IPF）中抗纤维化处理的资格取决于肺功能测试中使用的预测方程
2. PATIENT ELIGIBILITY FOR ANTI-FIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS CAN BE ALTERED BY USE OF DIFFERENT SETS OF REFERENCE VALUES FOR CALCULATION OF FVC PERCENT PREDICTED [J] . Ward K., Spurr L., Goldman N. R., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：可以通过使用不同的参考值集计算预测的FVC百分比来改变特发性肺纤维化患者抗纤维化治疗的患者合格率
3. Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted [J] . Ward Katie, Spurr Lydia, Goldman Nina R., Respiratory medicine . 2016,第Null期

机译：可以通过使用不同的参考值集计算预测的FVC百分比来改变患者在原发性肺纤维化中抗纤维化治疗的资格
4. Mga-Net: Multi-Scale Guided Attention Models for an Automated Diagnosis of Idiopathic Pulmonary Fibrosis (IPF) [C] . Wenxi Yu, Hua Zhou, Youngwon Choi, IEEE International Symposium on Biomedical Imaging . 2021

机译：MGA-NET：多尺度引导注意力模型，用于自动诊断特发性肺纤维化（IPF）
5. Unraveling the Role of Endoplasmic Reticulum Stress in Idiopathic Pulmonary Fibrosis (IPF) [D] . Burman, Ankita. 2019

机译：解开内质网胁迫在特发性肺纤维化（IPF）中的作用
6. AB051. Assessment of pulmonary function kai effect of treatment in patients with idiopathic pulmonary fibrosis (IPF) [O] . Ioannis Organtzis, Evangelia Fouka, Christoforos Efthymiou, 2016

机译：AB051。特发性肺纤维化（IPF）患者的肺功能改善效果评估
7. Eligibility for anti‐fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing [O] . Andrew Burgess, Ken Goon, John D. Brannan, 2019

机译：特发性肺纤维化中抗纤维化处理的资格取决于用于肺功能测试的预测方程

ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING

著录项

相似文献

相关主题

期刊订阅